Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cureus
|
February 12, 2026
Microbiome Differences in Preeclampsia Versus Lupus Nephritis
Harshita Nadella, Julia L Armstrong, Rachel Greenwald, et al.
Frontiers in Oncology
|
October 20, 2023
Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma
Caroline S Jansen, Yujin Choi, Sean T Evans, et al.
World Journal of Urology
|
January 9, 2025
Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry
Wei Chen, Hajime Tanaka, Masaki Kobayashi, et al.
Nature
|
October 24, 2024
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer
Maria A Cardenas, Nataliya Prokhnevska, Ewelina Sobierajska, et al.
Immunity
|
December 29, 2022
CD8<sup>+</sup> T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Nataliya Prokhnevska, Maria A Cardenas, Rajesh M Valanparambil, et al.
Journal for Immunotherapy of Cancer
|
July 21, 2022
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood
Jennifer Wilkinson Carlisle, Caroline S Jansen, Maria Andrea Cardenas, et al.
Urologic Oncology
|
June 26, 2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database
Franklin Liu, Luke Wang, Margaret F Meagher, et al.
Research Square
|
August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial
Mehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer
|
February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Mehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cureus
|
February 12, 2026
Microbiome Differences in Preeclampsia Versus Lupus Nephritis
Harshita Nadella, Julia L Armstrong, Rachel Greenwald, et al.
Frontiers in Oncology
|
October 20, 2023
Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma
Caroline S Jansen, Yujin Choi, Sean T Evans, et al.
World Journal of Urology
|
January 9, 2025
Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry
Wei Chen, Hajime Tanaka, Masaki Kobayashi, et al.
Nature
|
October 24, 2024
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer
Maria A Cardenas, Nataliya Prokhnevska, Ewelina Sobierajska, et al.
Immunity
|
December 29, 2022
CD8<sup>+</sup> T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Nataliya Prokhnevska, Maria A Cardenas, Rajesh M Valanparambil, et al.
Journal for Immunotherapy of Cancer
|
July 21, 2022
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood
Jennifer Wilkinson Carlisle, Caroline S Jansen, Maria Andrea Cardenas, et al.
Urologic Oncology
|
June 26, 2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database
Franklin Liu, Luke Wang, Margaret F Meagher, et al.
Research Square
|
August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial
Mehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer
|
February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Mehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Page
of 1